Duraflu by is a Otc medication manufactured, distributed, or labeled by Poly Pharmaceuticals, Inc.. Drug facts, warnings, and ingredients follow.
Liver warning: This product contains acetaminophen.
Severe liver damage may occur if you take:
Allergy alert: acetaminophen may cause severe skin reactions. Symptoms may include:
If a skin reaction occurs, stop use and seek medical help right away.
■ liver disease ■ heart disease ■ high blood pressure ■ thyroid disease ■ diabetes ■ trouble urinating ■ due to an enlarged prostate gland ■ persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema ■ cough that occurs with too much phlegm (mucus)
These could be signs of a serious condition
Adults and children 12 years of age and over: | 1 tablet every 4 hours, not to exceed 6 tablets in 24 hours or as directed by a doctor |
Children under 12 years of age | ½ tablet every 4 hours, not to exceed 3 tablets in 24 hours, or as directed by a doctor |
When using this product do not exceed recommended dosage.
DURAFLU
acetaminophen, dextromethorphan hbr, guaifenesin, pseudoephedrine hcl tablet |
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
Labeler - Poly Pharmaceuticals, Inc. (198449894) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
TG United | 172837085 | manufacture(50991-535) |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
DURAFLU 76297856 2712009 Live/Registered |
POLY PHARMACEUTICALS, INC. 2001-08-10 |